glp-1 gi obstruction lawsuit in west virginia The push to make weight-loss drugs more affordable is running into legal limits. Telehealth company Hims & Hers pulled a less expensive oral version of Wegovy after lawsuits from Novo Nordisk and Patients Are Suing Over Alleged
Description
Liquid calories in particular are problematic because they pass through the stomach quickly, minimizing the gastric emptying delay that tirzepatide relies on for satiety

The second most common complaint category

Express Scripts has the highest formulary inclusion rate but the lowest first-submission approval rate
Pair this analysis with our full 50-state breakdown of restaurant operating costs labor, rent, utilities, and taxes modeled for every state.

when they reached their maximum dose), people taking Wegovy were eating 35% fewer calories than those on placebo and experienced nearly a 10% reduction in their body weight
10.1016/j.jcmg.2008.05.012 35
